BCG vaccine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
BCG vaccine
Accession Number
DB12768
Type
Biotech
Groups
Investigational
Biologic Classification
Vaccines
Other vaccines
Description

BCG vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.

Synonyms
  • Bacillus calmette-guerin live antigen, unspecified substrain
  • BCG
Categories
UNII
8VJE55B0VG
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
2-MethoxyethanolThe risk or severity of infection can be increased when BCG vaccine is combined with 2-Methoxyethanol.
25-desacetylrifapentineThe therapeutic efficacy of BCG vaccine can be decreased when used in combination with 25-desacetylrifapentine.
6-Deoxyerythronolide BThe therapeutic efficacy of BCG vaccine can be decreased when used in combination with 6-Deoxyerythronolide B.
9-(N-methyl-L-isoleucine)-cyclosporin AThe risk or severity of infection can be increased when BCG vaccine is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
AbacavirThe therapeutic efficacy of BCG vaccine can be decreased when used in combination with Abacavir.
AbataceptThe risk or severity of infection can be increased when BCG vaccine is combined with Abatacept.
AbetimusThe risk or severity of infection can be increased when BCG vaccine is combined with Abetimus.
Acetic acidThe therapeutic efficacy of BCG vaccine can be decreased when used in combination with Acetic acid.
Acetyl sulfisoxazoleThe therapeutic efficacy of BCG vaccine can be decreased when used in combination with Acetyl sulfisoxazole.
ActeosideThe risk or severity of infection can be increased when BCG vaccine is combined with Acteoside.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911376
RxNav
1344
Wikipedia
BCG_vaccine
ATC Codes
L03AX03 — Bcg vaccine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedPreventionHealthy Volunteers / Tuberculosis Infection1
1CompletedPreventionTuberculosis Infection3
1CompletedTreatmentBreast Cancer1
1CompletedTreatmentCancer, Bladder1
1CompletedTreatmentNeuroblastomas / Sarcomas1
1CompletedTreatmentTransitional Cell Carcinoma of Bladder1
1CompletedTreatmentTuberculosis Infection1
1, 2CompletedPreventionTuberculosis Infection1
1, 2CompletedTreatmentColorectal Cancers1
1, 2Unknown StatusPreventionHuman Immunodeficiency Virus (HIV) Infections1
1, 2Unknown StatusTreatmentColorectal Cancers1
2CompletedNot AvailableCancer, Bladder1
2CompletedBasic SciencePlasmodium Falciparum / Plasmodium Infections1
2CompletedPreventionHuman Immunodeficiency Virus (HIV) Infections / Tuberculosis Infection1
2CompletedPreventionTuberculosis Infection2
2CompletedTreatmentCancer, Bladder4
2Not Yet RecruitingTreatmentDisseminated Sclerosis1
2Not Yet RecruitingTreatmentFibromyalgia1
2SuspendedPreventionTuberculosis Infection1
2TerminatedTreatmentMelanoma (Skin)1
2TerminatedTreatmentOvarian Cancer1
2Unknown StatusTreatmentProstate Cancer1
2, 3CompletedTreatmentSepsis1
2, 3RecruitingPreventionPrevention of TB Recurrence1
3Active Not RecruitingPreventionAllergies / Dermatitis, Eczematous / Respiratory Tract Infections (RTI)1
3CompletedPreventionHealthy Volunteers1
3CompletedPreventionPlasmodium Infections1
3CompletedTreatmentCancer, Bladder2
3CompletedTreatmentColorectal Cancers1
3CompletedTreatmentLung Cancers2
3RecruitingPreventionBloodstream Infections / Diarrhea / Lower Respiratory Infection / Lower Respiratory Tract Infection (LRTI) / Plasmodium Infections / Severe Illness1
3TerminatedTreatmentCancer, Bladder1
4Active Not RecruitingBasic ScienceWhooping Cough1
4CompletedPreventionBCG Infection / Immune Response / Reaction - Vaccine1
4CompletedPreventionClinical / Intervention / Prospective / Single-blind / Trial1
4CompletedPreventionTuberculosis Infection1
4TerminatedPreventionPlasmodium Infections1
Not AvailableCompletedBasic ScienceBCG Vaccination1
Not AvailableCompletedBasic ScienceInnate Immune Response2
Not AvailableNot Yet RecruitingPreventionBCG Vaccination Reaction1
Not AvailableRecruitingBasic ScienceNewborn Vaccine Immunogenicity1
Not AvailableUnknown StatusNot AvailableHealthy Volunteers / Tuberculosis Infection1
Not AvailableUnknown StatusPreventionDeath / Growth / Morbidity / Neonatal Mortality1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on October 20, 2016 18:07 / Updated on March 01, 2020 21:18

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates